Johns Hopkins Psychiatry Guide
Lofexidine
INDICATIONS
FDA
FDA
- Manage acute opioid withdrawal symptoms
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Opioid tapering
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 6, 2025
Citation
Weinstein, Sujin L. "Lofexidine." Johns Hopkins Psychiatry Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787449/5.2/Lofexidine.
Weinstein SL. Lofexidine. Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787449/5.2/Lofexidine. Accessed October 30, 2025.
Weinstein, S. L. (2025). Lofexidine. In Johns Hopkins Psychiatry Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787449/5.2/Lofexidine
Weinstein SL. Lofexidine [Internet]. In: Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. [cited 2025 October 30]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787449/5.2/Lofexidine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lofexidine
ID - 787449
A1 - Weinstein,Sujin,PharmD, BCPP
Y1 - 2025/10/06/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787449/5.2/Lofexidine
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
